These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9681245)

  • 1. Adjuvant action of Chenopodium quinoa saponins on the induction of antibody responses to intragastric and intranasal administered antigens in mice.
    Estrada A; Li B; Laarveld B
    Comp Immunol Microbiol Infect Dis; 1998 Jul; 21(3):225-36. PubMed ID: 9681245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin.
    Tochikubo K; Isaka M; Yasuda Y; Kozuka S; Matano K; Miura Y; Taniguchi T
    Vaccine; 1998; 16(2-3):150-5. PubMed ID: 9607023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions.
    Ekström J; Hu KF; Bengtsson KL; Morein B
    Vaccine; 1999 Jun; 17(20-21):2690-701. PubMed ID: 10418920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
    Israf DA; Lajis NH; Somchit MN; Sulaiman MR
    Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage.
    Externest D; Meckelein B; Schmidt MA; Frey A
    Infect Immun; 2000 Jul; 68(7):3830-9. PubMed ID: 10858191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
    Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased.
    Nedrud JG; Sigmund N
    Reg Immunol; 1990-1991; 3(5):217-22. PubMed ID: 1966580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoadjuvant activity, toxicity assays, and determination by UPLC/Q-TOF-MS of triterpenic saponins from Chenopodium quinoa seeds.
    Verza SG; Silveira F; Cibulski S; Kaiser S; Ferreira F; Gosmann G; Roehe PM; Ortega GG
    J Agric Food Chem; 2012 Mar; 60(12):3113-8. PubMed ID: 22394456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.
    Tamura S; Shoji Y; Hasiguchi K; Aizawa C; Kurata T
    Vaccine; 1994 Oct; 12(13):1238-40. PubMed ID: 7839730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
    Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
    J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of plant lectins with mucosal adjuvant activity.
    Lavelle EC; Grant G; Pusztai A; Pfüller U; O'Hagan DT
    Immunology; 2001 Jan; 102(1):77-86. PubMed ID: 11168640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal and systemic adjuvant effects of cholera toxin and Cry1Ac protoxin on the specific antibody response to HIV-1 C4/V3 peptides are different and depend on the antigen co-administered.
    Esquivel-Pérez R; Moreno-Fierros L
    Viral Immunol; 2005; 18(4):695-708. PubMed ID: 16359236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating peptide-linked polymers as carriers for mucosal vaccine delivery.
    Sakuma S; Suita M; Inoue S; Marui Y; Nishida K; Masaoka Y; Kataoka M; Yamashita S; Nakajima N; Shinkai N; Yamauchi H; Hiwatari K; Tachikawa H; Kimura R; Uto T; Baba M
    Mol Pharm; 2012 Oct; 9(10):2933-41. PubMed ID: 22953762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
    Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
    J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A murine model of enterohemorrhagic Escherichia coli O157:H7 infection to assess immunopotentiating activity of drugs on mucosal immunity: effect of drugs.
    Nagano K; Sugisaki T; Taguchi K; Hara T; Naiki M; Mori H
    J Pharmacol Sci; 2003 Mar; 91(3):219-28. PubMed ID: 12686745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
    Zhang P; Yang QB; Marciani DJ; Martin M; Clements JD; Michalek SM; Katz J
    Vaccine; 2003 Oct; 21(27-30):4459-71. PubMed ID: 14505929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.